Incyte Corporation (INCY)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
JAKAFI Product Revenue	3.14B	3.09B	2.79B
JAKAFI Product Revenue Growth	1.56%	10.76%	7.65%
OPZELURA Product Revenue	702.77M	678.46M	508.29M
OPZELURA Product Revenue Growth	3.58%	33.48%	50.44%
ICLUSIG Product Revenue	139.99M	134.07M	114.32M
ICLUSIG Product Revenue Growth	4.42%	17.28%	2.42%
PEMAZYRE Product Revenue	90.83M	86.73M	81.75M
PEMAZYRE Product Revenue Growth	4.73%	6.09%	-2.26%
MINJUVI/MONJUVI Product Revenue	164.25M	144.58M	119.24M
MINJUVI/MONJUVI Product Revenue Growth	13.61%	21.25%	221.76%
NIKTIMVO Product Revenue	193.11M	151.64M	-
NIKTIMVO Product Revenue Growth	27.35%	-	-
ZYNYZ Product Revenue	104.74M	66.35M	3.19M
ZYNYZ Product Revenue Growth	57.85%	1983.23%	154.80%
Total Product Revenue	4.54B	4.35B	3.62B
Total Product Revenue Growth	4.18%	20.32%	14.34%
JAKAVI Royalty Revenue	471.14M	457.73M	418.84M
JAKAVI Royalty Revenue Growth	2.93%	9.29%	13.94%
OLUMIANT Royalty Revenue	150.21M	144.60M	135.57M
OLUMIANT Royalty Revenue Growth	3.88%	6.66%	-0.42%
TABRECTA Royalty Revenue	26.27M	26.70M	22.75M
TABRECTA Royalty Revenue Growth	-1.61%	17.39%	27.84%
Other Royalty Revenue	9.86M	7.88M	2.17M
Other Royalty Revenue Growth	25.15%	262.87%	10.37%
Total Royalty Revenue	657.48M	636.91M	579.33M
Total Royalty Revenue Growth	3.23%	9.94%	10.67%
Milestone and Contract Revenue	167.00M	150.00M	43.00M
Milestone and Contract Revenue Growth	11.33%	248.84%	514.29%
Revenue (Other)	-193.11M	-151.64M	1,000.00
Revenue (Total)	5.36B	5.14B	4.24B
Revenue (Total) Growth	4.28%	21.22%	14.76%

Updated Apr 28, 2026. Data Source: Fiscal.ai.